• Publications
  • Influence
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
Treatment of postmenopausal osteoporosis with strontium ranelate leads to early and sustained reductions in the risk of vertebral fractures. Expand
Prevalence of Vitamin D Insufficiency in an Adult Normal Population
The results showed that in French normal adults living in an urban environment with a lack of direct exposure to sunshine, diet failed to provide an adequate amount of vitamin D, and the clinical utility of winter supplementation with low doses ofitamin D was discussed. Expand
Body mass index as a predictor of fracture risk: A meta-analysis
It is concluded that low BMI confers a risk of substantial importance for all fractures that is largely independent of age and sex, but dependent on BMD. Expand
Estimates of optimal vitamin D status
Based on the available evidence, it is believed that if older men and women maintain serum levels of 25(OH)D that are higher than the consensus median threshold of 75 nmol/l, they will be at lower risk of fracture. Expand
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.
This study shows that strontium ranelate significantly reduces the risk of all nonvertebral and in a high-risk subgroup, hip fractures over a 3-yr period, and is well tolerated. Expand
Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women
The effects of supplementation with vitamin D3 (cholecalciferol) and calcium on the frequency of hip fractures and other nonvertebral fractures, identified radiologically, in 3270 healthy ambulatory women are studied. Expand
Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis
Harry K. Genant (Chairman) , Cyrus Cooper (Rapporteur) , Gyula Poor (Rapporteur) , Ian Reid (Rapporteur) , George Ehrlich (Editor), J. Kanis (Editor), B. E. Christopher Nordin (Editor), Elizabet hExpand
Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
Zoledronic acid infusions given at intervals of up to one year produce effects on bone turnover and bone density as great as those achieved with daily oral dosing with bisphosphonates with proven efficacy against fractures, suggesting that an annual infusion of zoledronic Acid might be an effective treatment for postmenopausal osteoporosis. Expand
Vitamin D3 and calcium to prevent hip fractures in elderly women.
BACKGROUND Hypovitaminosis D and a low calcium intake contribute to increased parathyroid function in elderly persons. Calcium and vitamin D supplements reduce this secondary hyperparathyroidism, butExpand
Predictive Value of BMD for Hip and Other Fractures
The relationship between BMD and fracture risk was estimated in a meta‐analysis of data from 12 cohort studies of ∼39,000 men and women. Low hip BMD was an important predictor of fracture risk. TheExpand